Medicare Enrolled

Dr. David Morledge, M.D.

Neurology · Austin, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
711 W 38TH ST, Austin, TX 78705
5124586121
In practice since 2006 (19 years)
NPI: 1225129703 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Morledge from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Morledge? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Morledge

Dr. David Morledge is a neurology in Austin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Morledge performed 32,594 Medicare services across 607 unique beneficiaries.

Between the years covered by Open Payments, Dr. Morledge received a total of $158,270 from 102 pharmaceutical and/or device companies across 1503 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Morledge is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 2% volume in TX$ $158,270 industry payments

Medicare Practice Summary

Medicare Utilization ↗
32,594
Medicare services
Top 2% in TX for neurology
607
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,715 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit24,555$5$14
Botox injection (Xeomin), per unit7,000$4$14
Office visit, established patient (30-39 min)345$90$222
Office visit, established patient (20-29 min)132$57$144
Hospital follow-up visit, moderate complexity120$60$161
Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box75$121$307
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity65$71$140
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity62$84$212
Hospital follow-up visit, low complexity57$36$91
Injection of chemical for paralysis of nerve muscles on side of face52$147$536
Office visit, established patient, complex (40-54 min)43$131$302
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face38$107$350
New patient office visit (45-59 min)19$110$355
Initial hospital admission, moderate complexity19$97$301
EEG, extended monitoring12$369$960
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$158,270
Total received (2018-2024)
Avg $22,610/year across 7 years
Top 4% in TX for neurology
102
Companies
1,503
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137,420 (86.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,614 (11.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,236 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$19,547
2023
$19,404
2022
$26,242
2021
$23,817
2020
$17,553
2019
$21,119
2018
$30,589

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$55,711
Biogen, Inc.
$22,701
Allergan, Inc.
$20,446
US WorldMeds, LLC
$15,389
AbbVie Inc.
$14,967
Allergan Inc.
$8,726
Genentech, Inc.
$2,020
Teva Pharmaceuticals USA, Inc.
$1,387
Novartis Pharmaceuticals Corporation
$1,228
Genentech USA, Inc.
$1,190
EMD Serono, Inc.
$890
Amgen Inc.
$729
Sunovion Pharmaceuticals Inc.
$687
ACADIA Pharmaceuticals Inc
$668
GENZYME CORPORATION
$666
UCB, Inc.
$548
Acorda Therapeutics, Inc
$540
Alexion Pharmaceuticals, Inc.
$502
Medtronic USA, Inc.
$481
Lilly USA, LLC
$464
MDD US Operations, LLC
$459
Supernus Pharmaceuticals, Inc.
$441
SK Life Science, Inc.
$386
Celgene Corporation
$328
Lundbeck LLC
$321
Abbott Laboratories
$318
Neurocrine Biosciences, Inc.
$298
Adamas Pharmaceuticals, Inc.
$287
Amneal Pharmaceuticals LLC
$274
PFIZER INC.
$274
Avanir Pharmaceuticals, Inc.
$239
Boston Scientific Corporation
$232
Akcea Therapeutics, Inc.
$231
GE HEALTHCARE
$224
Biohaven Pharmaceuticals, Inc.
$196
LivaNova USA, Inc.
$179
Merz North America, Inc.
$167
E.R. Squibb & Sons, L.L.C.
$166
Merz Pharmaceuticals, LLC
$149
Kyowa Kirin, Inc.
$144
Biohaven Pharmaceutical Holding Company Ltd.
$143
ARBOR PHARMACEUTICALS, INC.
$122
Upsher-Smith Laboratories LLC
$121
Corium, LLC
$121
Bausch Health US, LLC
$114
ARGENX US, INC.
$112
Takeda Pharmaceuticals U.S.A., Inc.
$108
Amylyx Pharmaceuticals, Inc.
$108
MITSUBISHI TANABE PHARMA AMERICA, INC.
$100
JAZZ PHARMACEUTICALS INC.
$95
Octapharma USA, Inc.
$95
Grifols USA, LLC
$91
Janssen Pharmaceuticals, Inc
$88
Eisai Inc.
$87
BOSTON SCIENTIFIC CORPORATION
$86
Sumitomo Pharma America, Inc.
$82
Assertio Therapeutics, Inc.
$72
AbbVie, Inc.
$62
Saol Therapeutics Inc.
$59
ANI Pharmaceuticals, Inc.
$59
UPSHER-SMITH LABORATORIES LLC
$56
AQUESTIVE THERAPEUTICS, INC.
$52
Arbor Pharmaceuticals, Inc.
$50
Bayer HealthCare Pharmaceuticals Inc.
$47
GE HealthCare
$44
SANOFI-AVENTIS U.S. LLC
$42
GRT US Holding, Inc.
$41
Vertical Pharmaceuticals, LLC
$39
Collegium Pharmaceutical, Inc.
$37
Mallinckrodt LLC
$36
CSL Behring
$36
Medtronic, Inc.
$34
Zyla Life Sciences, Inc.
$32
Promius Pharma LLC
$32
Egalet US Inc
$32
BioDelivery Sciences International, Inc.
$29
Strongbridge US INC.
$28
Kedrion Biopharma, Inc.
$25
InSightec,Inc
$24
Banner Life Sciences, LLC
$24
Zyla Life Sciences
$22
MERZ NORTH AMERICA, INC.
$21
Retrophin, Inc.
$20
TG Therapeutics, Inc.
$19
IMPEL PHARMACEUTICALS INC.
$19
EISAI INC.
$18
Amarin Pharma Inc.
$18
HOSPIRA, INC.
$17
Neurelis, Inc.
$17
Avion Pharmaceuticals
$17
CATALYST PHARMACEUTICALS, INC.
$16
OWP Pharmaceuticals, Inc.
$16
Mitsubishi Tanabe Pharma America, Inc.
$15
Aprecia Pharmaceuticals, LLC
$15
Jazz Pharmaceuticals Inc.
$14
AstraZeneca Pharmaceuticals LP
$14
Shire North American Group Inc
$14
Scilex Pharmaceuticals Inc.
$13
Mylan Pharmaceuticals Inc.
$12
Neuronetics, Inc.
$12
Impax Laboratories, Inc.
$11
Purdue Pharma L.P.
$11
Top 3 companies account for 62.5% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ACTIVA · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adempas · Adlarity · Aduhelm · Aimovig · Albuked · Apokyn · Aptiom · Austedo XR · Azstarys · BAFIERTAM · BELBUCA · BIONIC NAVIGATOR · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · COPAXONE · Cambia · DUOPA · Deep Brain Stimulation · Dhivy · Duopa · ELYXYB - celecoxib · EMGALITY · Evekeo · Exablate · FIRDAPSE · Fintepla · GAMMAGARD · GENERAL DBS · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Glatiramer Acetate · Gocovri · Hizentra · Horizant · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LIORESAL (BACLOFEN) · LYRICA · Leqembi · Lioresal (baclofen) · Lioresal Intrathecal (baclofen injection) · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PROCLAIM · PURIFIED CORTROPHIN GEL · Percept · Ponvory · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · RELEXXII · RELYVRIO · RYTARY · Radicava · Rebif · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · SYMPROIC · Soliris · Spritam · Subvenite · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vascepa · Vercise · Vimpat · Vyvanse · XARELTO · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZINBRYTA · ZIPSOR · ZOMIG · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in TX.

Equivalent to $486 per 100 Medicare services performed
Looking for a neurology in Austin?
Compare neurologys in the Austin area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
126
Per 100K population
9.6
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Morledge is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (speaking/promotional, top 4%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Morledge experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Morledge performed 24,555 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Morledge receive payments from pharmaceutical companies?
Yes. Dr. Morledge received a total of $158,270 from 102 companies across 1,503 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Morledge's costs compare to other neurologys in Austin?
Dr. Morledge's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Morledge) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →